|
|
Article: Review shows amoxicillin/clavulanate effective for bacterial rhinosinusitis.
- Article from:
- Pharma Business Week
- Article date:
- September 13, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 SEP 13 - (NewsRx.com & NewsRx.net) -- A specially engineered formulation of amoxicillin/clavulanate, GlaxoSmithKline's Augmentin XR (amoxicillin/clavulanate potassium) Extended Release Tablets, is effective in treating acute bacterial rhinosinusitis (ABRS), according to a review published in Clinics in Laboratory Medicine.
This is despite significant prevalence of resistance to commonly used antimicrobials in bacteria that cause ABRS. The evolution of amoxicillin/clavulanate in the treatment of adults with ABRS and community- acquired pneumonia (CAP) in response to antimicrobial resistance patterns was reviewed by Michael R. Jacobs, MD, PhD, Thomas M. File, ...